These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 21682552

  • 1. Simplifying anemia management in hemodialysis patients: ESAs administered at longer dosing intervals can enhance opportunities to provide patient-focused care.
    Schiller B, Besarab A.
    Curr Med Res Opin; 2011 Aug; 27(8):1539-50. PubMed ID: 21682552
    [Abstract] [Full Text] [Related]

  • 2. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T.
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bundled-rate legislation for Medicare reimbursement for dialysis services: implications for anemia management with ESAs.
    Charytan C.
    Clin J Am Soc Nephrol; 2010 Dec; 5(12):2355-62. PubMed ID: 21071515
    [Abstract] [Full Text] [Related]

  • 6. Meeting new challenges in the management of anemia of chronic kidney disease through collaborative care with pharmacists.
    Bacchus S, O'Mara N, Manley H, Fishbane S.
    Ann Pharmacother; 2009 Nov; 43(11):1857-66. PubMed ID: 19826095
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration.
    Lawler EV, Gagnon DR, Fink J, Seliger S, Fonda J, Do TP, Gaziano JM, Bradbury BD.
    Nephrol Dial Transplant; 2010 Jul; 25(7):2237-44. PubMed ID: 20083469
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Costs of managing anemia with erythropoiesis-stimulating agents during hemodialysis: a time and motion study.
    Schiller B, Doss S, DE Cock E, Del Aguila MA, Nissenson AR.
    Hemodial Int; 2008 Oct; 12(4):441-9. PubMed ID: 19090867
    [Abstract] [Full Text] [Related]

  • 12. An expert opinion on the current treatment of anemia in patients with kidney disease.
    Locatelli F, Del Vecchio L.
    Expert Opin Pharmacother; 2012 Mar; 13(4):495-503. PubMed ID: 22296648
    [Abstract] [Full Text] [Related]

  • 13. Survey of attitude of physicians on updates in the management of anemia in chronic kidney disease patients.
    Souqiyyeh MZ, Shaheen FA.
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):410-6. PubMed ID: 19414943
    [Abstract] [Full Text] [Related]

  • 14. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW, Shetty S, del Aguila MA, Nelson MA, Murray BM.
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Time savings associated with C.E.R.A. once monthly: a time-and-motion study in hemodialysis centers in five European countries.
    De Cock E, Dellanna F, Khellaf K, Klatko W, Maduell F, Raluy-Callado M, Villa G.
    J Med Econ; 2013 Nov; 16(5):648-56. PubMed ID: 23402559
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The controversy surrounding hemoglobin and erythropoiesis-stimulating agents: what should we do now?
    Singh AK.
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S5-13. PubMed ID: 19010260
    [Abstract] [Full Text] [Related]

  • 19. Individualizing decision-making--resurrecting the doctor-patient relationship in the anemia debate.
    Agarwal R.
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1340-6. PubMed ID: 20448071
    [Abstract] [Full Text] [Related]

  • 20. Continuous erythropoietin receptor activator (Mircera) for renal anemia.
    McGahan L.
    Issues Emerg Health Technol; 2008 Feb; (113):1-6. PubMed ID: 18354858
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.